跳至主要内容
临床试验/JPRN-jRCT1051210145
JPRN-jRCT1051210145招募中3 期

Efficacy of therapeutic intervention with vedolizumab for ulcerative colitis patients with no or mild symptom and uncontrolled endoscopic activity: A multicenter- non-randomized trial

ooi makoto0 个研究点目标入组 150 人开始时间: 2021年12月28日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 80age old(—)
性别
All

入选标准

  • (1) patients from 18 to 80 years
  • (2) patients with clinical diagnosis of ulcerative colitis
  • (3) patients treated with mesalazine and/or thiopurine over 6 months
  • (4) Mayo endoscopic score of 2 or more
  • (5) Mayo score of 2 or less with each sub-score of 1 or less
  • (6) Those who can fill out the consent form about participation in this clinical research by themselves.

排除标准

  • (1)pregnant or breastfeeding women (2)patients with active infection (3)patients with malignancy or history of malignancy (4)patients treated with corticosteroid within 12 weeks before the commencement of the study (5)patients treated with cyclosporine or tacrolimus within 2 weeks before the commencement of the study (6)patients with the past history of anti TNF alpha antibody, JAK inhibitor, or ustekinumab treatment (7)patients with the past history of vedolizumab treatment (8)inappropriate patients by doctor's judgement

研究者

发起方
ooi makoto

相似试验